The research company Inhalation Sciences receives SEK 400,000 through its participation in the international research project BioInhale. The project has been allocated a total of SEK 8.2 million in funding from the Knowledge Foundation via Malmö University.BioInhale is intended to increase knowledge of how inhaled drugs are absorbed and act in the body. Inhalation Sciences' contribution includes studies using the company's IPL technology, and the project runs from December 2026 to November 2029."We are very pleased to be part of the BioInhale project. This is exactly the kind of collaboration that drives science forward and strengthens our position as a leading player in inhalation research. Working together with prominent academic and industry partners to deepen the understanding of how inhaled drugs act at the molecular level is fully in line with our strategy and vision," says Manoush Masarrat, CEO of Inhalation Sciences, in a comment.